BRD-K57371763-001-01-7 (Substance)
[(2R,3S,4S,5S,6R)-6-[[(5E,8S,9Z,11S,12S,13Z,15E,18R)-12-[(2R,3R,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate
Compound (Entity type)Analyze
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K57371763-001-01-7's neighborhood in the knowledge graph.
Results found
Linked to
| Label | Description |
|
|---|---|---|---|
 | A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the L1000 Phase2 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the LINCS 2021 project | ||
| A biosample from LINCS produced as part of the L1000 Phase2 project |
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the L1000 Phase2 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the LINCS 2021 project
A biosample from LINCS produced as part of the L1000 Phase2 project